Takayama Red Cross Hospital

Recent papers from Takayama Red Cross Hospital

1. Characteristics of Clinical Response in Patients With Chronic Myeloid Leukemia With an ABL1 In‐Frame Exon 4 Deletion: A Multicenter Retrospective StudyeJHaem · 2026
2. Timing of Endoscopic Biliary Drainage for Acute Cholangitis Associated with Common Bile Duct Stones in Elderly Patients: A Single-Center Retrospective Cohort StudyJournal of Clinical Medicine · 2026
3. Reply to the Letter to the Editor Regarding “Age and Nocturnal Polyuria in Nocturia: A Multicenter Voiding Diary Cohort Study”Neurourology and Urodynamics · 2026
4. Age and Nocturnal Polyuria in Nocturia: A Multicenter Voiding Diary Cohort StudyNeurourology and Urodynamics · 2026
5. Lifelong Attachment System Asian Model of Family TherapyJournal of Marital and Family Therapy · 2026
6. A Case of HNRNPU ‐Related Neurodevelopmental Disorder Presenting With Acute Encephalopathy and Basal Ganglia LesionsCongenital Anomalies · 2026
7. Intra-Abdominal Desmoid-Type Fibromatosis Occurring during Chemotherapy for Multiple Hepatic Recurrences after Resection of a Small Intestinal Neuroendocrine Tumor: A Case ReportThe Japanese Journal of Gastroenterological Surgery · 2026
8. Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 VaccinationInternal Medicine · 2026
9. Monochorionic diamniotic twins with developmental lactose intolerance that improved before a corrected age of 40 weeks: Report of two casesPediatrics International · 2026
10. Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell LymphomaHematological Oncology · 2025
11. Pulmonary edema following subarachnoid hemorrhage is associated with impairment of pulmonary vascular endothelial glycocalyxBiochemistry and Biophysics Reports · 2025
12. Detrimental Effect of Early Clazosentan Administration on Neurogenic Pulmonary Edema Following Subarachnoid Hemorrhage and Safety of Its Delayed Administration: Laboratory InvestigationWorld Neurosurgery · 2025
13. Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world studyAnnals of Hematology · 2025
14. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer: A dramatic recovery after chemotherapyInternal Medicine · 2025
15. Balancing Rehabilitation Dose in Acute Stroke Decision-Making and Global Assessment (The BRIDGE Study)Journal of Clinical Medicine · 2025
16. Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R- CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: A real- world study2025
17. Predictive value of immune-modified Glasgow prognostic score in patients with head and neck squamous cell carcinoma treated with nivolumabThe Journal of Laryngology & Otology · 2025
18. Severe pharyngeal stenosis and laryngomalacia in an individual of HNRNPU ‐related neurodevelopmental disorder associated with a novel nonsense variantCongenital Anomalies · 2025
19. Forest bathing improves inflammatory markers, SpO2, and subjective symptoms related to chronic obstructive pulmonary disease (COPD) in male subjects at risk of developing COPDJournal of Occupational Health · 2025
20. An Extremely Rare Case of Primary Malignant Melanoma of the KidneyWorld Journal of Oncology · 2024